Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1595888 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$543,681 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
13 quarters on record

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Derivatives in GALT

reported options exposure · as of Jun 30, 2026
CallValue
$86,768
CallShares
18,700
PutValue
$72,384
PutShares
15,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in GALT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $72,384 15,600
2026-06-30 $86,768 18,700
2026-03-31 $467,046 167,400
2026-03-31 $543,681 194,868
2025-12-31 $750,048 180,300
2025-12-31 $829,249 199,339
2025-09-30 $62,225 14,676
2025-06-30 $1,579,655 748,652
2024-12-31 $115,455 89,500
2024-12-31 $90,429 70,100
2024-03-31 $87,915 36,785
2023-12-31 $56,056 33,769
2023-03-31 $85,096 40,522
2022-12-31 $39,999 35,398
2021-12-31 $87,147 42,100
2021-09-30 $182,748 47,100
2021-06-30 $40,320 12,600
2021-06-30 $35,625 11,133